PLX - Protalix BioTherapeutics, Inc.

QQQ $ 593.31 $ 5.98 (1.02 %)

DIA $ 464.13 $ 4.66 (1.01 %)

SPY $ 661.53 $ 6.49 (1 %)

TLT $ 89.43 $ -0.23 (-0.26 %)

GLD $ 375.71 $ 1.73 (0.46 %)

Previous Close

$ 1.74

Open

$ 1.74

Bid

$ 1.74 x 2,310

Ask

$ 1.75 x 473

Day's Range

$ 1.71 - $ 1.79

52 Week Range

$ 1.32 - $ 3.10

Volume

605,353

Average Volume

Market Cap

139.93M

Beta (5Y Monthly)

$ 0.82

PE Ratio (TTM)

$ 25.94

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Prota...
11/21/2025 11:21:33

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Protalix BioTherapeutics (AMEX:PLX) with a Buy and lowers the p...

Protalix BioTherapeutics Q3 EPS $0.03 Miss...
11/13/2025 11:51:16

Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate ...

Earnings Scheduled For November 13, 2025
11/13/2025 11:11:32

Preview: Protalix BioTherapeutics's Earnings
11/12/2025 17:02:12

Protalix BioTherapeutics Unit Requests Ree...
11/03/2025 21:33:09

Chiesi Global Rare Diseases, a business unit of the Chiesi Group, and Protalix BioTherapeutics, Inc. (NYSE American: PLX), have...

why-is-protalix-biotherapeutics-stock-falling-on-friday

Why Is Protalix BioTherapeutics Stock Fall...
10/17/2025 15:23:15

EMA issues a negative opinion on Protalix and Chiesi's Elfabrio revised dosing for Fabry disease, citing insufficient data ...

12 Health Care Stocks Moving In Friday's P...
10/17/2025 12:13:10

Protalix BioTherapeutics Says CHMP Denies ...
10/17/2025 11:03:02

12 Health Care Stocks Moving In Thursday's...
10/02/2025 21:06:15

Protalix BioTherapeutics Q2 Sales $15.658M...
08/14/2025 10:51:53

Protalix BioTherapeutics (AMEX:PLX) reported quarterly sales of $15.658 million which beat the analyst consensus estimate of $1...

Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

Preview: Protalix BioTherapeutics's Earnings
08/13/2025 17:02:31

Protalix BioTherapeutics Appoints Gilad Ma...
07/21/2025 10:51:50

Protalix BioTherapeutics Added To Russell ...
06/30/2025 10:52:45

12 Health Care Stocks Moving In Friday's P...
05/09/2025 12:10:06

Protalix BioTherapeutics Q1 EPS $(0.05) Mi...
05/09/2025 10:53:23

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate ...

Earnings Scheduled For May 9, 2025
05/09/2025 08:32:15

Uncovering Potential: Protalix BioTherapeu...
05/08/2025 18:02:54

protalix-biotherapeutics-says-with-debt-fully-repaid-its-well-positioned-to-execute-strategy-through-2025-and-beyond

Protalix BioTherapeutics Says With Debt Fu...
03/17/2025 15:56:28

Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start ...

Protalix BioTherapeutics FY 2024 GAAP EPS ...
03/17/2025 11:00:39

Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of...